ChiCTR2100053475 版本V1.1 版本创建时间2022/07/01 22:13:02 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100053475 

最近更新日期:

Date of Last Refreshed on:

2021-11-22 15:02:57 

注册时间:

Date of Registration:

2021-11-22 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

角膜绷带镜在MGD患者白内障术后的临床应用研究

Public title:

The clinical application study of corneal bandage lens after cataract surgery in MGD patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

角膜绷带镜在MGD患者白内障术后的临床应用研究

Scientific title:

The clinical application study of corneal bandage lens after cataract surgery in MGD patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

潘彦丽 

研究负责人:

李元彬 

Applicant:

panyanli 

Study leader:

liyuanbin 

申请注册联系人电话:

Applicant telephone:

13361178018

研究负责人电话:

Study leader's telephone:

李元彬

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1152011640@qq.com

研究负责人电子邮件:

Study leader's E-mail:

yuanbinli@yeah.net

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东省烟台市毓璜顶东路20号

研究负责人通讯地址:

山东省烟台市毓璜顶东路20号

Applicant address:

No.20, Yuhuangding East Road, Yantai City, Shandong Province

Study leader's address:

No.20, Yuhuangding East Road, Yantai City, Shandong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

烟台毓璜顶医院

Applicant's institution:

Yantai Yuhuangding Hospital

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021-363

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

烟台毓璜顶医院伦理委员会

Name of the ethic committee:

Yantai Yuhuangding Hospital Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2021-11-04 00:00:00

伦理委员会联系人:

高振利

Contact Name of the ethic committee:

gaozhenli

伦理委员会联系地址:

山东省烟台市毓璜顶东路20号毓璜顶医院

Contact Address of the ethic committee:

Yuhuangding Hospital, No.20, Yuhuangding East Road, Yantai City, Shandong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

烟台毓璜顶医院

Primary sponsor:

Yantai Yuhuangding Hospital

研究实施负责(组长)单位地址:

山东省烟台市毓璜顶东路20号毓璜顶医院

Primary sponsor's address:

Yuhuangding Hospital, No.20, Yuhuangding East Road, Yantai City, Shandong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东

市(区县):

烟台

Country:

China

Province:

Shandong

City:

Yantai

单位(医院):

烟台毓璜顶医院

具体地址:

毓璜顶东路20号

Institution
hospital:

Yantai Yuhuangding Hospital

Address:

20 Yuhuangding Road East

经费或物资来源:

烟台毓璜顶医院眼科病房

Source(s) of funding:

Yantai Yuhuangding Hospital ophthalmology ward

Target disease:

dry eyes

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

评价角膜绷带镜治疗MGD患者白内障术后干眼的临床效果,总结分析其有效性和安全性。  

Objectives of Study:

To evaluate the clinical effect of keratoscopy in the treatment of MGD patients with dry eye after cataract surgery, and to summarize and analyze its effectiveness and safety.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1、轻度MGD患者2、年龄相关性白内障患者;3、晶状体核硬度分级Ⅱ级;4、年龄45~80岁,性别不限;5、双眼先后行白内障手术者,仅纳入第一只眼;6、有正常认知能力,能配合问卷调查和相关眼科检查;

Inclusion criteria

1. Patients with mild MGD 2. Patients with age-related cataract; 3, lens nuclear hardness grade II; 4. Age from 45 to 80, no gender limitation; 5. For cataract surgery in both eyes, only the first eye was included; 6. Have normal cognitive ability and can cooperate with questionnaire survey and ophthalmic examination;

排除标准:

1、有较严重全身疾病患者;2、患有中、重度MGD或其他眼部疾病的患者,如眼部过敏、沙眼、类天疱疮、化学损伤、热烧伤、辐射损伤、眼睑异常(如眼睑内翻和外翻)、眼睑痉挛、低眼压、倒睫和上睑下垂、Sj?gren综合征、青光眼或高眼压;3、眼部手术或眼外伤史;4、试验前1周内局部或全身使用过糖皮质激素或者非固醇类抗炎药以及免疫抑制剂;

Exclusion criteria:

1. Patients with serious systemic diseases; 2. Patients with moderate or severe MGD or other eye diseases, such as ocular allergy, trachoma, pemphigoid, chemical injury, heat burn, radiation injury, eyelid abnormalities (such as varus and eversion of eyelid), blepharospasm, hypoocular pressure, trichiasis and ptosis, Sjogren's syndrome, glaucoma or high ocular pressure; 3. History of eye surgery or eye trauma; 4. Local or systemic use of glucocorticoids, non-steroidal anti-inflammatory drugs and immunosuppressants within 1 week before the trial;

研究实施时间:

Study execute time:

From 2020-06-01 00:00:00 To 2021-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-06-01 00:00:00 To 2021-03-15 00:00:00  

干预措施:

Interventions:

组别:

试验(BCL)组

样本量:

30

Group:

Experiment (BCL) group

Sample size:

干预措施:

角膜绷带镜

干预措施代码:

Intervention:

bandage contact lens

Intervention code:

组别:

对照组

样本量:

30

Group:

The control group

Sample size:

干预措施:

干预措施代码:

Intervention:

no

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东 

市(区县):

烟台 

Country:

china 

Province:

Shandong 

City:

Yantai 

单位(医院):

烟台毓璜顶医院 

单位级别:

三级甲等 

Institution
hospital:

Yantai Yuhuangding Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

最佳矫正视力

指标类型:

主要指标

Outcome:

best corrected visual actuity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

角膜荧光素钠染色

指标类型:

主要指标

Outcome:

cornea fluorescein staining

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

非侵入式首次泪膜破裂时间

指标类型:

主要指标

Outcome:

non-invasive first break-up time

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

眼表疾病指数

指标类型:

主要指标

Outcome:

Ocular Surface Disease Index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

裂隙灯检查

指标类型:

主要指标

Outcome:

slit-lamp examination

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由本研究实验者通过数字排序(奇数佩戴绷带镜)半随机佩戴角膜绷带镜。

Randomization Procedure (please state who generates the random number sequence and by what method):

The subjects in this study wore the corneal bandage lens semi-randomly by numerical order (odd number of patients wearing the bandage lens).

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不适用

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

不适用

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

不适用

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Inapplicability

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-11-22 15:02:51